Cargando…
Abnormal expression of CEBPB promotes the progression of renal cell carcinoma through regulating the generation of IL-6
BACKGROUND: The CCAAT/enhancer-binding protein beta (CEBPB), a transcription factor regulating immune and inflammatory responses, has been implicated in the pathogenesis of various malignancies. However, its specific regulatory mechanism in renal cell carcinoma (RCC) remains poorly understood. METHO...
Autores principales: | Ren, Yaoqiang, Guo, Wenke, Qiao, Baoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520310/ https://www.ncbi.nlm.nih.gov/pubmed/37767481 http://dx.doi.org/10.1016/j.heliyon.2023.e20175 |
Ejemplares similares
-
Nintedanib Alleviates Experimental Colitis by Inhibiting CEBPB/PCK1 and CEBPB/EFNA1 Pathways
por: Li, Hailong, et al.
Publicado: (2022) -
Silencing of CEBPB-AS1 modulates CEBPB expression and resensitizes BRAF-inhibitor resistant melanoma cells to vemurafenib
por: Vidarsdottir, Linda, et al.
Publicado: (2020) -
PGAM1 regulation of ASS1 contributes to the progression of breast cancer through the cAMP/AMPK/CEBPB pathway
por: Liu, Min, et al.
Publicado: (2022) -
ZBTB7/miR-137 Autoregulatory Circuit Promotes the Progression of Renal Carcinoma
por: Wang, Lihui, et al.
Publicado: (2019) -
Prospective signs of cleidocranial dysplasia in Cebpb deficiency
por: Huang, Boyen, et al.
Publicado: (2014)